LONGEVITY BIOTECH Trademark

Trademark Overview

On Tuesday, February 7, 2023, a trademark application was filed for LONGEVITY BIOTECH with the United States Patent and Trademark Office. The USPTO has given the LONGEVITY BIOTECH trademark a serial number of 97784579. The federal status of this trademark filing is REGISTERED as of Tuesday, November 18, 2025. This trademark is owned by Longevity Biotech, Inc.. The LONGEVITY BIOTECH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the prevention and treatment of neurological disorders; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of diabetes; Pharmaceutical products for the treatment of autioimmune conditions; Pharmaceutical products for the immunomodulation therapeutic treatment of immune-mediated diseases

Pharmaceutical research services; Laboratory research services relating to pharmaceuticals; Pharmaceutical product evaluation; Pharmaceutical products development
longevity biotech

General Information

Serial Number97784579
Word MarkLONGEVITY BIOTECH
Filing DateTuesday, February 7, 2023
Status700 - REGISTERED
Status DateTuesday, November 18, 2025
Registration Number8033225
Registration DateTuesday, November 18, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of neurological disorders; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of diabetes; Pharmaceutical products for the treatment of autioimmune conditions; Pharmaceutical products for the immunomodulation therapeutic treatment of immune-mediated diseases
NOT AVAILABLE"BIOTECH"
Goods and ServicesPharmaceutical research services; Laboratory research services relating to pharmaceuticals; Pharmaceutical product evaluation; Pharmaceutical products development

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code005
First Use Anywhere DateMonday, December 31, 2018
First Use In Commerce DateMonday, December 31, 2018
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 27, 2023
Primary Code042
First Use Anywhere DateFriday, December 18, 2009
First Use In Commerce DateFriday, December 18, 2009

Trademark Owner History

Party NameLongevity Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameLongevity Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameLongevity Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Friday, February 10, 2023NEW APPLICATION ENTERED
Monday, February 27, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 3, 2023ASSIGNED TO EXAMINER
Tuesday, November 21, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, February 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, December 4, 2024SOU EXTENSION 1 FILED
Thursday, February 13, 2025SOU EXTENSION 1 GRANTED
Tuesday, February 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 7, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, May 13, 2025HIDDEN SENSITIVE CONTENT
Thursday, July 31, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 31, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 31, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 31, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 31, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 7, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 7, 2025USE AMENDMENT FILED
Tuesday, October 7, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, October 31, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 31, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 18, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, November 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

biotech longevity pharmaceutical products treatment services research diseases laboratory pharmaceuticals development evaluation